Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Pevonedistat in Combination With Induction Chemotherapy for Adolescent and Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin Lymphoma

NCT03349281 is registered in ClinicalTrials.gov with Julio Barredo, MD as lead sponsor.

NCT NCT03349281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Pevonedistat in Combination With Induction Chemotherapy for Adolescent and Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin Lymphoma
Lead sponsor
Julio Barredo, MD
Phase
Phase 1
Overall status
Completed
Start date
March 25, 2019
Completion date
October 12, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory acute lymphoblastic leukemia, relapsed acute lymphoblastic leukemia